Search - tctmd.com

Displaying 41 - 60 of 60

Sort: Relevancy | Date

News Daily News

Meta-analysis Reassures on Benefits of TAVR in Cancer Patients

L.A. McKeown

March 16, 2020

News Conference News ISET 2020

PAD Care on the Backdrop of Cancer Requires Creativity, Persistence

Caitlin E. Cox

January 23, 2020

News Features

The Cancer Patient Needing PCI Poses Conundrums for Care

Shelley Wood

January 14, 2020

News Conference News VEITH 2019

More Real-world Data Support Safety of Paclitaxel-Based Devices in PAD

L.A. McKeown

November 22, 2019

News Conference News VIVA 2019

Clinicians Get Real on Radiation: ‘Don’t Do Dumb Things’

L.A. McKeown

November 07, 2019

News Conference News TCT 2019

LEVANT: Patient-Level Data Show No Increase in 5-Year Death for Paclitaxel DCBs in PAD

L.A. McKeown

September 28, 2019

News Daily News

MI Definitions in SCOT-HEART Prompt Outcry—Then Silence—on Twitter

Shelley Wood

September 19, 2019

News Daily News

TCTMD’s Top 10 Most Popular Stories for July 2019

Shelley Wood

July 31, 2019

News Daily News

FDA Grants Cardiac MR Indication for Gadavist Contrast Injection

Shelley Wood

July 16, 2019

News Daily News

Sudden, ‘Biologically Implausible’ Rise in Valsartan-Linked Neoplasms After 2018 Recall

Marcus A. Banks

July 12, 2019

News Conference News TVT 2019

Vast Numbers of Severe Symptomatic AS Patients Untreated? A Plea and Some Pushback

Shelley Wood

June 14, 2019

News Conference News CRT 2019

Acknowledgment of Safety Signal for Paclitaxel Devices in PAD May Mark Sea Change in Controversy

L.A. McKeown

March 06, 2019

News Daily News

A Day of Data: Signal of Mortality Increase With Paclitaxel Devices in PAD Continues to Vex

L.A. McKeown

March 01, 2019

News Conference News STS 2019

No ‘July Effect’ Observed in Cardiac Surgery

Yael L. Maxwell

February 05, 2019

News Daily News

Industry, Investigators Push Back With Patient-Level Data Showing No Increased Death From Paclitaxel-Based PAD Therapies

L.A. McKeown

January 23, 2019

News Daily News

Cancer Patients Should Not Be Automatically Ruled Out for TAVR: Analysis

L.A. McKeown

January 10, 2019

News Daily News

Appropriate Use Criteria Tackle Imaging in Nonvalvular Structural Heart Disease

Caitlin E. Cox

January 07, 2019

News Daily News

Operators’ Radiation Exposure in the Cath Lab Directly Tied to Patient BMI

Todd Neale

January 04, 2019

News Daily News

Current or Prior Cancers Affect PCI Outcomes Differently, Large Analysis Shows

L.A. McKeown

December 04, 2018

News Conference News ESC 2018

ESC 2018: Trimming DAPT, New NOAC Niches, Aspirin Scrutiny for Primary Prevention, and More

Shelley Wood

August 20, 2018

Advertisement

Meta-analysis Reassures on Benefits of TAVR in Cancer Patients

PAD Care on the Backdrop of Cancer Requires Creativity, Persistence

The Cancer Patient Needing PCI Poses Conundrums for Care

More Real-world Data Support Safety of Paclitaxel-Based Devices in PAD

Clinicians Get Real on Radiation: ‘Don’t Do Dumb Things’

LEVANT: Patient-Level Data Show No Increase in 5-Year Death for Paclitaxel DCBs in PAD

MI Definitions in SCOT-HEART Prompt Outcry—Then Silence—on Twitter

TCTMD’s Top 10 Most Popular Stories for July 2019

FDA Grants Cardiac MR Indication for Gadavist Contrast Injection

Sudden, ‘Biologically Implausible’ Rise in Valsartan-Linked Neoplasms After 2018 Recall

Vast Numbers of Severe Symptomatic AS Patients Untreated? A Plea and Some Pushback

Acknowledgment of Safety Signal for Paclitaxel Devices in PAD May Mark Sea Change in Controversy

A Day of Data: Signal of Mortality Increase With Paclitaxel Devices in PAD Continues to Vex

No ‘July Effect’ Observed in Cardiac Surgery

Industry, Investigators Push Back With Patient-Level Data Showing No Increased Death From Paclitaxel-Based PAD Therapies

Cancer Patients Should Not Be Automatically Ruled Out for TAVR: Analysis

Appropriate Use Criteria Tackle Imaging in Nonvalvular Structural Heart Disease

Operators’ Radiation Exposure in the Cath Lab Directly Tied to Patient BMI

Current or Prior Cancers Affect PCI Outcomes Differently, Large Analysis Shows

ESC 2018: Trimming DAPT, New NOAC Niches, Aspirin Scrutiny for Primary Prevention, and More

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content